Wilms10T Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The Wilms10T cell line was derived from a primary Wilms tumor sample obtained from a patient with Wilms tumor, a pediatric nephroblastoma. This cell line is characterized by a homozygous deletion of the WT1 gene, leading to a complete loss of WT1 function, a critical gene involved in kidney development and the maintenance of normal renal differentiation. Unlike many other Wilms tumor cell lines, Wilms10T lacks any WT1 protein expression, which is reflective of the severe genetic alterations present in this tumor subtype. Additionally, the Wilms10T cell line exhibits loss of heterozygosity (LOH) in the 11p15 chromosomal region, which includes important genes like IGF2, further contributing to its tumorigenic properties. Wilms10T cells have a stable normal karyotype with no major chromosomal rearrangements apart from the specific deletion of the WT1 region. This cell line has been utilized extensively to study the effects of complete WT1 loss on tumor biology, including its impact on cell proliferation, differentiation, and response to various signaling pathways. The cells retain mesenchymal characteristics, expressing markers such as vimentin, while lacking epithelial markers like cytokeratin, indicative of their stromal origin. Significant research has focused on the signaling pathways active in Wilms10T cells. Proteomic studies have demonstrated that these cells show activation of several receptor tyrosine kinases (RTKs) such as IGF1R, PDGFRβ, and AXL, which are known to drive tumorigenesis. Additionally, downstream signaling pathways, including the MAPK and PI3K/AKT pathways, are activated in Wilms10T cells, contributing to their aggressive tumor phenotype. The comprehensive characterization of Wilms10T makes it a valuable model for investigating the molecular underpinnings of Wilms tumor with complete WT1 loss, as well as for exploring potential therapeutic targets in this aggressive tumor subtype. |
|---|---|
| 生物體 | Human |
| 組織 | Kidney |
| 疾病 | Wilms tumor |
| 應用 | In vitro cell culture model and biochemical studies |
| 同義詞 | Wilms10 |
特徵
| 年齡 | 2 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 形態學 | Spindle-shaped |
| 細胞類型 | Wilms cells |
| 生長特性 | Adherent |
監管數據
| 引用 | Wilms10T (Cytion catalog number 300417) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_A5SL |
生物分子資料
| 突變譜 | WT1 mutation status: homozygous del WT1 within del11p13. LOH: no in 11p13 but UPD in 11p15. CTNNB1 mutation status: homozygous del TCT, p.DS45, UPD 3p |
|---|
處理方式
| 培養基 | MSCGM kit (from Lonza) |
|---|---|
| 解離試劑 | Accutase |
| 倍增時間 | 46 hours |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 播種密度 | 4 x 104 cells/cm2 |
| 流體更新 | 1 to 2 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 300417-221 | 分析證明書 | 23. May. 2025 | 300417 |
| 300417-131025 | 分析證明書 | 05. Dec. 2025 | 300417 |